ETrade Capital Management’s Emergent Biosolutions EBS Stock Holding History

ETrade Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.03M	Buy	9,968 +18	+0.2%	+$1.94K	0.02%	361
2020 Q2	$786K	Buy	+9,950	New	+$741K	0.02%	427
2019 Q1	–	Sell	-29,062	Closed	-$1.72M	–	812
2018 Q4	$1.72M	Buy	29,062 +871	+3%	+$56.1K	0.06%	200
2018 Q3	$1.86M	Sell	28,191 -249	-0.9%	-$14.5K	0.05%	210
2018 Q2	$1.44M	Buy	28,440 +1,141	+4%	+$59.4K	0.04%	246
2018 Q1	$1.44M	Buy	+27,299	New	+$1.36M	0.05%	230
2016 Q3	–	Sell	-25,137	Closed	-$707K	–	533
2016 Q2	$707K	Sell	25,137 -1,368	-5%	-$53.6K	0.04%	285
2016 Q1	$963K	Buy	26,505 +141	+0.5%	+$4.98K	0.05%	211
2015 Q4	$1.05M	Buy	26,364 +1,135	+4%	+$39.6K	0.06%	179
2015 Q3	$719K	Buy	25,229 +2,888	+13%	+$95.2K	0.04%	234
2015 Q2	$736K	Buy	22,341 +1,113	+5%	+$34.5K	0.04%	222
2015 Q1	$611K	Buy	21,228 +1,449	+7%	+$41.6K	0.04%	254
2014 Q4	$539K	Buy	19,779 +3,396	+21%	+$80.9K	0.03%	284
2014 Q3	$349K	Buy	+16,383	New	+$375K	0.02%	333

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

ETrade Capital Management's EBS Position: Q3 2020 in Review

ETrade Capital Management increased its Emergent Biosolutions (EBS) stake by 0.18% in Q3 2020, buying an estimated $1.94K and bringing the position to 9,968 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #361.

ETrade Capital Management first reported a position in EBS in Q3 2014 and has held it in 14 quarters since. The position peaked at $1.86M in Q3 2018. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

ETrade Capital Management held 9,968 shares of Emergent Biosolutions worth $1.03M as of Q3 2020.
ETrade Capital Management bought 18 Emergent Biosolutions shares in Q3 2020, an estimated $1.94K.
Emergent Biosolutions made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #361 holding.
ETrade Capital Management first reported a position in Emergent Biosolutions in Q3 2014 and has held it in 14 quarters since.
ETrade Capital Management's Emergent Biosolutions position peaked at $1.86M in Q3 2018.
358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.